7-44153411-A-T
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP2PP3_StrongPP5
The NM_000162.5(GCK):c.98T>A(p.Val33Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V33A) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000162.5 missense
Scores
Clinical Significance
Conservation
Publications
- hyperinsulinism due to glucokinase deficiencyInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- maturity-onset diabetes of the young type 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
- monogenic diabetesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- diabetes mellitus, noninsulin-dependentInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- permanent neonatal diabetes mellitus 1Inheritance: AR Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- transient neonatal diabetes mellitusInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- maturity-onset diabetes of the youngInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- permanent neonatal diabetes mellitusInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GCK | NM_000162.5 | c.98T>A | p.Val33Glu | missense_variant | Exon 2 of 10 | ENST00000403799.8 | NP_000153.1 | |
| GCK | NM_033507.3 | c.101T>A | p.Val34Glu | missense_variant | Exon 2 of 10 | NP_277042.1 | ||
| GCK | NM_033508.3 | c.95T>A | p.Val32Glu | missense_variant | Exon 3 of 11 | NP_277043.1 | ||
| GCK | NM_001354800.1 | c.98T>A | p.Val33Glu | missense_variant | Exon 2 of 11 | NP_001341729.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Maturity-onset diabetes of the young type 2 Pathogenic:1
- -
Maturity onset diabetes mellitus in young Uncertain:1
The p.V33E variant (also known as c.98T>A), located in coding exon 2 of the GCK gene, results from a T to A substitution at nucleotide position 98. The valine at codon 33 is replaced by glutamic acid, an amino acid with dissimilar properties. This variant has not been reported in the literature; however, another alteration in the same codon, p.V33A, has been identified in multiple Czech families with maturity-onset diabetes of the young (Lukásová P et al. Physiol Res, 2008 Feb;57 Suppl 1:S99-108; Pruhova S et al. Pediatr Diabetes, 2010 Dec;11:529-35; Dusatkova P et al. Pediatr Diabetes, 2012 Sep;13:489-98).The p.V33E variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on available evidence to date, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at